"Kaplan-Meier Estimate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
| Descriptor ID |
D053208
|
| MeSH Number(s) |
E05.318.740.998.650 N05.715.360.750.795.650 N06.850.520.830.998.650
|
| Concept/Terms |
Kaplan-Meier Estimate- Kaplan-Meier Estimate
- Estimate, Kaplan-Meier
- Kaplan-Meier Test
- Kaplan Meier Test
- Test, Kaplan-Meier
- Product-Limit Method
- Method, Product-Limit
- Methods, Product-Limit
- Product Limit Method
- Product-Limit Methods
- Kaplan-Meier Analysis
- Analysis, Kaplan-Meier
- Kaplan Meier Analysis
Kaplan-Meier Survival Curves- Kaplan-Meier Survival Curves
- Curves, Kaplan-Meier Survival
- Kaplan Meier Survival Curves
- Survival Curves, Kaplan-Meier
|
Below are MeSH descriptors whose meaning is more general than "Kaplan-Meier Estimate".
Below are MeSH descriptors whose meaning is more specific than "Kaplan-Meier Estimate".
This graph shows the total number of publications written about "Kaplan-Meier Estimate" by people in this website by year, and whether "Kaplan-Meier Estimate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 13 | 13 |
| 2008 | 0 | 16 | 16 |
| 2009 | 0 | 42 | 42 |
| 2010 | 0 | 33 | 33 |
| 2011 | 0 | 47 | 47 |
| 2012 | 0 | 63 | 63 |
| 2013 | 1 | 42 | 43 |
| 2014 | 1 | 55 | 56 |
| 2015 | 0 | 55 | 55 |
| 2016 | 0 | 42 | 42 |
| 2017 | 0 | 69 | 69 |
| 2018 | 0 | 44 | 44 |
| 2019 | 0 | 39 | 39 |
| 2020 | 0 | 31 | 31 |
| 2021 | 0 | 9 | 9 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 14 | 15 |
| 2025 | 0 | 7 | 7 |
| 2026 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kaplan-Meier Estimate" by people in Profiles.
-
The influence of HLA matching on graft survival in lung transplant recipients is indication specific: a UNOS database analysis. Eur Respir J. 2026 Sep; 68(3).
-
Lung transplantation for pulmonary alveolar proteinosis: a retrospective international multicentre analysis. Eur Respir J. 2026 Aug; 68(2).
-
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities across Patient Groups with Prostate Cancer. Clin Cancer Res. 2026 Aug 03; 32(15):3381-3394.
-
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med. 2026 Apr 02; 394(13):1257-1269.
-
The prognostic value of systemic inflammatory response index (SIRI) and CD8?+?tumor-infiltrating lymphocytes for patients with localized undifferentiated pleomorphic sarcoma of soft tissue. BMC Cancer. 2025 Dec 15; 25(1):1870.
-
Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (Alliance). J Natl Cancer Inst. 2025 Dec 01; 117(12):2643-2652.
-
Survival differences in pulmonary metastatic osteosarcoma between pediatric and adult institutions. J Pediatr Surg. 2026 Jan; 61(1):162738.
-
Clinically Interpretable Survival Risk Stratification in Head and Neck Cancer Using Bayesian Networks and Markov Blankets. Int J Radiat Oncol Biol Phys. 2026 03 01; 124(3):856-867.
-
Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial. Ann Surg Oncol. 2025 Oct; 32(11):8113-8126.
-
Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer. N Engl J Med. 2025 Jun 19; 392(23):2346-2356.